Sharekhan

Entero Healthcare Solutions Ltd

Mon 6/04/2026,15:59:4 | NSE : ENTERO

₹ 1234.40-14.70 (-1.18%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1250.00

Previous Close

₹ 1249.10

Volume

26980

Mkt Cap ( Rs. Cr)

₹5370.99

High

₹ 1260.00

Low

₹ 1225.20

52 Week High

₹ 1510.80

52 Week Low

₹ 944.00

Book Value Per Share

₹ 413.73

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Entero Healthcare Solutions Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

1234.40

10

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

10

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Entero Healthcare Solutions Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Entero Healthcare - Trading Window

    23 Mar 2026, 5:29PM Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) R
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Change in Management

    11 Mar 2026, 8:10PM Change in Senior Management Personnel
  • Entero Healthcare - Resignation

    11 Mar 2026, 8:09PM Entero Healthcare Solutions Limited has informed the Exchange regarding Resignation of Mr. Sambit Mohanty as Senior Management Personnel of the compan
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Mar 2026, 8:04PM Intimation of Schedule of Analyst/Institutional Investor meet to be held on March 11, 2026.
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Mar 2026, 8:04PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Mar 2026, 7:51PM Intimation of Schedule of Analyst/Institutional Investor meet to be held on March 09, 2026
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Mar 2026, 7:51PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    26 Feb 2026, 7:28PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 Feb 2026, 7:27PM Intimation of Schedule of Analyst/Institutional Investor meet to be held on March 06, 2026
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    20 Feb 2026, 1:08PM Transcript of Earnings call
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Feb 2026, 1:08PM Entero Healthcare Solutions Limited has informed the Exchange about Transcript
  • Entero Healthcare So - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025 Wit

    13 Feb 2026, 6:09PM Unaudited Financial results for the quarter and nine months ended December 31, 2025 with UDIN
  • Entero Healthcare So - General Updates

    13 Feb 2026, 6:09PM Entero Healthcare Solutions Limited has informed the Exchange about Unaudited Financial Results of the Company for the quarter and nine months ended D
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    13 Feb 2026, 3:54PM Recording of Earnings call/ Conference call
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Feb 2026, 3:54PM Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording
  • Entero Healthcare So - Copy of Newspaper Publication

    13 Feb 2026, 1:24PM Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication
  • Entero Healthcare So - Outcome of Board Meeting

    12 Feb 2026, 8:33PM Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
  • Entero Healthcare So - Investor Presentation

    12 Feb 2026, 8:11PM Entero Healthcare Solutions Limited has informed the Exchange about Investor Presentation
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Investor Presentation

    12 Feb 2026, 8:11PM Investor presentation
  • Entero Healthcare So - Monitoring Agency Report

    12 Feb 2026, 8:07PM Submission of Monitoring Agency Report issued by ICRA Limited for the quarter ended December 31, 2025.
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    12 Feb 2026, 8:07PM Monitoring agency report for the quarter ended December 31, 2025
  • Entero Healthcare So - Intimation For Grant Of Fresh 5,000 ESOP

    12 Feb 2026, 7:55PM Grant of fresh ESOP
  • Entero Healthcare So - ESOP/ESOS/ESPS

    12 Feb 2026, 7:55PM Entero Healthcare Solutions Limited has informed the Exchange regarding Grant of 5000 Options.
  • Entero Healthcare So - Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025

    12 Feb 2026, 7:43PM Submission of unaudited financial results for the quarter and nine months ended December 31, 2025
  • Entero Healthcare So - Outcome of Board Meeting

    12 Feb 2026, 7:41PM Entero Healthcare Solutions Limited has informed the Exchange regarding Outcome of Board Meeting held on February 12, 2026
  • Entero Healthcare So Q3 net profit down 92.49% at Rs 0.81 cr

    12 Feb 2026, 7:40PM The company reported standalone net profit of Rs 0.81 crore for the quarter ended December 31, 2025 as compared to Rs 10.78 crore in the same period l
  • Entero Healthcare So - Outcome of Board Meeting

    12 Feb 2026, 7:25PM Entero Healthcare Solutions Limited has informed the Exchange regarding Board meeting held on February 12, 2026.
  • Entero Healthcare So - Board Meeting Outcome for Outcome Of The Board Meeting Held On February 12, 2026

    12 Feb 2026, 7:25PM Outcome of the Board meeting held on February 12, 2026
  • Entero Healthcare So - Press Release

    9 Feb 2026, 12:40PM Entero Healthcare Solutions Limited has informed the Exchange regarding a press release dated February 09, 2026, titled ""Acquisition Update: Entero H
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    9 Feb 2026, 12:40PM The Company has informed the Exchange about the Media Release/ Press Release
  • Entero Healthcare So - General Updates

    7 Feb 2026, 6:36PM Entero Healthcare Solutions Limited has informed the Exchange about Update on Acquisition
  • Entero Healthcare So - Update On Acquisition

    7 Feb 2026, 6:33PM Update on Acquisition
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Feb 2026, 3:10PM Intimation of Earnings call on unaudited Financial Results of the Company for the Quarter and nine months ended December 31, 2025
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Feb 2026, 3:10PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Board Meeting Intimation for Approval Of The Financial Results For The Quarter Ended December 31, 2025

    3 Feb 2026, 6:45PM Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to c
  • Entero Healthcare So - General Updates

    27 Jan 2026, 7:50PM Entero Healthcare Solutions Limited has informed the Exchange about temporary suspension of drug licenses of Atreja Healthcare Solutions Private Limit
  • Entero Healthcare So has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    19 Jan 2026, 3:40PM As of December 2025, 52.42% is owned by Promoters and 47.58% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 14.41% and F
  • Entero Healthcare So - General Updates

    15 Jan 2026, 10:20AM Entero Healthcare Solutions Limited has informed the Exchange about General Updates
  • Entero Healthcare So - Change Of Name Of M/S. M S K A & Associates, Chartered Accountants, Statutory Auditor Of The Company -

    15 Jan 2026, 10:20AM Change of name of Statutory Auditor - upon its conversion from Firm into LLP

Key fundamentals

Evaluate the intrinsic value of Entero Healthcare Solutions Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1650.38 1626.414 675.232 581.205 486.4381
Liabilities 1650.38 1626.414 675.232 581.205 486.4381
Equity 43.508 43.494 4.112 3.85 0.1002
Gross Profit -30.346 -34.494 -43.916 -53.716 -36.9478
Net Profit 19.181 38.44 -12.455 -40.847 -18.1512
Cash From Operating Activities -109.016 -75.65 -56.909 -44.698 -68.1958
NPM(%) 4.69 12.08 -7 -29.75 -18.17
Revenue 408.67 318.161 177.69 137.286 99.8955
Expenses 439.016 352.655 221.606 191.002 136.8433
ROE(%) 1.06 2.13 -0.69 -2.26 -1

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Entero Healthcare Solutions Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 650.10 -0.69 38.60 704.93 301.39 0.77
Lotus Eye Hospital and Institute Ltd 104.43 1.87 336.87 2568.65 3.55 0.00
Vaishali Pharma Ltd 5.85 -2.17 0.00 16114.03 3.13 0.00
Astec Lifesciences Ltd 545.20 0.41 0.00 2422.30 -604.75 0.00

Company Info

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Parent Organisation

Entero Healthcare Solutions Ltd.

Founded

10/01/2018

Managing Director

Mr.Prabhat Agrawal

NSE Symbol

ENTEROEQ

FAQ

OPEN FREE* DEMAT ACCOUNT